Business● Low37m ago · Nov 13, 2026, 5:31 AM
Reviva Pharmaceuticals GAAP EPS of -$0.17 beats by $0.23
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Reviva Pharmaceuticals reported GAAP EPS of -$0.17, which exceeded expectations by $0.23. This indicates a financial update for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business3m ago15 suspects detained in Istanbul money laundering investigationAnadolu Ajansı [tr] · TürkiyeBusiness5m agoGlobal markets are mixedAnadolu Ajansı [tr] · TürkiyeBusiness8m agoQatar records a deficit of $6.25 billion in the third quarter of 2026Sky News Arabia · United Arab EmiratesBusiness9m agoDollar to Naira exchange rate today, November 13, 2026Vanguard Nigeria